KD Logo

Investing in Ocular Therapeutix Inc (OCUL): What You Must Know

Ocular Therapeutix Inc’s recent filing unveils that its 10% Owner SUMMER ROAD LLC acquired Company’s shares for reported $7.0 million on Feb 26 ’24. In the deal valued at $7.52 per share,930,851 shares were bought. As a result of this transaction, SUMMER ROAD LLC now holds 8,591,401 shares worth roughly $48.63 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Mattessich Antony C. sold 18,338 shares, generating $90,773 in total proceeds. Upon selling the shares at $4.95, the President and CEO now owns 427,943 shares.

Before that, Ozden Rabia Gurses sold 7,764 shares. Ocular Therapeutix Inc shares valued at $38,432 were divested by the Chief Medical Officer at a price of $4.95 per share. As a result of the transaction, Ozden Rabia Gurses now holds 92,767 shares, worth roughly $0.53 million.

BofA Securities initiated its Ocular Therapeutix Inc [OCUL] rating to a Buy in a research note published on February 09, 2024; the price target was $15. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. H.C. Wainwright revised its rating on August 10, 2021. It rated OCUL as “a Buy” which previously was an “a Neutral”.

Price Performance Review of OCUL

On Friday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock fall -3.08% to $5.66. Over the last five days, the stock has lost -8.27%. Ocular Therapeutix Inc shares have risen nearly 26.91% since the year began. Nevertheless, the stocks have fallen -12.79% over the past one year. While a 52-week high of $11.31 was reached on 03/06/24, a 52-week low of $2.00 was recorded on 01/19/24. SMA at 50 days reached $7.86, while 200 days put it at $4.97. A total of 2.18 million shares were traded, compared to the trading of 1.72 million shares in the previous session.

Levels Of Support And Resistance For OCUL Stock

The 24-hour chart illustrates a support level at 5.36, which if violated will result in even more drops to 5.05. On the upside, there is a resistance level at 5.96. A further resistance level may holdings at 6.25. The Relative Strength Index (RSI) on the 14-day chart is 41.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.48%. Stochastics %K at 72.38% indicates the stock is a holding.

Most Popular